New research may help ease concerns about the effect of drugs like Ozempic on muscles while also underscoring the importance ...

The Centers for Medicare & Medicaid Services will provide eligible Medicare beneficiaries monthly access to certain GLP-1 medications for $50 per month beginning July 1, 2026, through December 31, ...

A new study suggests GLP-1 weight-loss drugs may be able to do more than curb appetite. Here's what researchers found.

A recently published study found that social judgments extend beyond whether you lose weight or not, but also to how you do ...

Two years ago, Jennifer Kirtley looked down at the scale and saw 328 pounds. Today, she’s looking in the mirror at a size 6.

Scientists are learning that GLP-1s may be an effective weight-loss medication for so many people because, in part, they ...

The data shows that the drugs triggered activity in the central amygdala that reduced dopamine release into the brain's reward circuitry.

Companies have “tremendous concern” about the financial viability of these medications, the president and CEO of the Business ...

An online platform settled with the Connecticut attorney general's office Wednesday and agreed to stop selling GLP-1 ...

Compounded semaglutide, tirzepatide and liraglutide could be harder to come by starting this summer, if the U.S. Food and ...

UCSF experts share their research on medications’ potential to slow or reduce risk of dementia and to treat the triggers that ...